Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia
Public ClinicalTrials.gov record NCT05124275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream BID for the Treatment of Presbyopia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Multicenter, Randomized, Double-Masked Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia.
Study identification
- NCT ID
- NCT05124275
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 123 participants
Conditions and interventions
Conditions
Interventions
- Pilocarpine Ophthalmic Topical Cream, Dose 1 Drug
- Pilocarpine Ophthalmic Topical Cream, Dose 2 Drug
- Pilocarpine Ophthalmic Topical Cream, Dose 3 Drug
- Placebo Ophthalmic Topical Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2022 (Actual)
- Primary completion
- Sep 6, 2022 (Actual)
- Completion
- Sep 6, 2022 (Actual)
- Last update posted
- Sep 1, 2023
2022
United States locations
- U.S. sites
- 10
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Glaukos Investigator | Chandler | Arizona | 85224 | — |
| Glaukos Investigator | Sun City | Arizona | 85351 | — |
| Glaukos Investigator | Glendale | California | 91204 | — |
| Glaukos Investigator | Newport Beach | California | 92663 | — |
| Glaukos Investigator | Petaluma | California | 94954 | — |
| Glaukos Investigator | Louisville | Kentucky | 40206 | — |
| Glaukos Investigator | Rochester | New York | 14618 | — |
| Glaukos Investigator | Memphis | Tennessee | 38119 | — |
| Glaukos Investigator | Houston | Texas | 77025 | — |
| Glaukos Investigator | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05124275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 1, 2023 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05124275 live on ClinicalTrials.gov.